Litcius/Paper detail

Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction

Danielle Rasooly, Claudia Giambartolomei, Gina M. Peloso, Hesam Dashti, Brian R. Ferolito, Daniel J Golden, Andréa R. V. R. Horimoto, Maik Pietzner, Eric Farber‐Eger, Quinn S. Wells, Giorgio Bini, Gabriele Proietti, Gian Gaetano Tartaglia, Nicole Kosik, Peter W.F. Wilson, Lawrence S. Phillips, Patricia B. Munroe, Steffen E. Petersen, Kelly Cho, J. Michael Gaziano, Andrew R. Leach, VA Million Veteran Program, John C. Whittaker, Claudia Langenberg, Nay Aung, Yan V. Sun, Alexandre C. Pereira, Juan P. Casas, Jacob Joseph

2025Nature Cardiovascular Research15 citationsDOIOpen Access PDF

Topics & Concepts

Ejection fractionOmicsHeart failureScale (ratio)Fraction (chemistry)DrugMedicineComputational biologyInternal medicineCardiologyBiologyPharmacologyBioinformaticsChemistryGeographyChromatographyCartographyCardiovascular Function and Risk FactorsCardiomyopathy and Myosin StudiesHeart Failure Treatment and Management
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction | Litcius